Metronidazole Injection recalled over sterility concerns
- Recall date
- March 10, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Claris Lifesciences Inc recalls Metronidazole Injection, USP, 500 mg/100 mL, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08…
- Recall number
- D-0616-2017
- FDA classification
- Class II
- Brand / firm
- Claris Lifesciences Inc
- Sold / distributed
- Nationwide
Why it was recalled
Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Metronidazole Injection, USP, 500 mg/100 mL, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-001-24
Get recall alerts
Free email alert whenever Claris Lifesciences Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Claris Lifesciences Inc